Every trade that managers of CBD Global Sciences Inc. disclose to SEDI is tracked on this page. The past year has been quiet: not a single insider filing for CBD Global Sciences Inc. The previous disclosure was published on 12 January 2022.
Looking back to 2019, when coverage begins, insiders filed no purchases and 8 sales.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
15 of 15 declarations
CBD Global Sciences Inc. is a company focused on developing cannabidiol-based products. It operates on the Toronto Stock Exchange (XTSE).